WFG Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
WFG Advisors's BMY Position: Q2 2017 in Review
WFG Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.9% in Q2 2017, buying an estimated $72.3K and bringing the position to 23,928 shares worth $1.33M. The position accounts for 0.3% of the portfolio, ranked #89.
WFG Advisors first reported a position in BMY in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.58M in Q4 2015. 1,594 funds tracked by Wall St. Rank hold BMY as of Q2 2017.
- WFG Advisors held 23,928 shares of Bristol-Myers Squibb worth $1.33M as of Q2 2017.
- WFG Advisors bought 1,328 Bristol-Myers Squibb shares in Q2 2017, an estimated $72.3K.
- Bristol-Myers Squibb made up 0.3% of WFG Advisors's portfolio in Q2 2017, its #89 holding.
- WFG Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 17 quarters since.
- WFG Advisors's Bristol-Myers Squibb position peaked at $1.58M in Q4 2015.
- 1,594 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2017.
Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.